Latest Myotonia Stories
ISIS-DMPK Rx Extends the Targeting of Antisense Drugs to Include Muscle Tissue CARLSBAD, Calif., Dec. 16, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
RnRMarketResearch.com adds Sarcoidosis and Myotonic Dystrophy Pipeline Review H2 2014 to its store.
Networking event at MIT Museum will build bridges among stakeholders in the quest for treating muscle diseases HACKENSACK, N.J., Nov.
After a 21-year battle with Myotonic Dystrophy, Brian Malmgren, age 43, passed away on the afternoon of July 30th, 2014.
SAN FRANCISCO, Feb.
Scientists have revealed an atomic-level view of a genetic defect that causes a form of muscular dystrophy, myotonic dystrophy type 2, and have used this information to design drug candidates with potential to counter those defects—and reverse the disease.
Preliminary research finds that for patients with nondystrophic myotonias (NDMs), rare diseases that affect the skeletal muscle and cause functionally limiting stiffness and pain, use of the anti-arrhythmic medication mexiletine resulted in improvement in patient-reported stiffness.
Muscle atrophy a major problem with arthritis, could be treated with regenerative medicine, according to A.J.